230 related articles for article (PubMed ID: 1831870)
1. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma.
Nagai H; Kitagaki K; Goto S; Suda H; Koda A
Jpn J Pharmacol; 1991 May; 56(1):13-21. PubMed ID: 1831870
[TBL] [Abstract][Full Text] [Related]
2. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
McPherson GA; Stork AP
Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
[TBL] [Abstract][Full Text] [Related]
3. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
Yanagisawa T; Teshigawara T; Taira N
Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
[TBL] [Abstract][Full Text] [Related]
5. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
Satoh H
J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
Eltze M
Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
[TBL] [Abstract][Full Text] [Related]
7. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y
Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882
[TBL] [Abstract][Full Text] [Related]
8. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.
Yanagisawa T; Hashimoto H; Taira N
Br J Pharmacol; 1988 Oct; 95(2):393-8. PubMed ID: 2852521
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC
Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450
[TBL] [Abstract][Full Text] [Related]
10. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
Satoh E; Yanagisawa T; Taira N
Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
Ksoll E; Parsons AA; Mackert JR; Schilling L; Wahl M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
Atwal KS
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
[TBL] [Abstract][Full Text] [Related]
13. Interaction of potassium channel openers and blockers in canine atrial muscle.
Yanagisawa T; Hashimoto H; Taira N
Br J Pharmacol; 1989 Jul; 97(3):753-62. PubMed ID: 2527073
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vitro effects of K+ channel modulators on detrusor and portal vein strips from guinea pigs.
Zografos P; Li JH; Kau ST
Pharmacology; 1992; 45(4):216-30. PubMed ID: 1438528
[TBL] [Abstract][Full Text] [Related]
15. Prejunctional effects of cromakalim, nicorandil and pinacidil on noradrenergic transmission in rat isolated mesenteric artery.
Fabiani ME; Story DF
J Auton Pharmacol; 1994 Apr; 14(2):87-98. PubMed ID: 8051201
[TBL] [Abstract][Full Text] [Related]
16. Essential role of nucleotide diphosphates in nicorandil-mediated activation of cardiac ATP-sensitive K+ channel. A comparison with pinacidil and lemakalim.
Shen WK; Tung RT; Machulda MM; Kurachi Y
Circ Res; 1991 Oct; 69(4):1152-8. PubMed ID: 1834361
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
Taylor SG; Arch JR; Bond J; Buckle DR; Shaw DJ; Taylor JF; Ward JS
J Pharmacol Exp Ther; 1992 May; 261(2):429-37. PubMed ID: 1578358
[TBL] [Abstract][Full Text] [Related]
18. Effects of pinacidil, cromakalim, and nicorandil on potassium currents of rat basilar artery smooth muscle.
Zhang H; Stockbridge N; Weir B
Adv Exp Med Biol; 1991; 304():531-41. PubMed ID: 1839488
[No Abstract] [Full Text] [Related]
19. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
Garrino MG; Plant TD; Henquin JC
Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
[TBL] [Abstract][Full Text] [Related]
20. Epithelium-dependent inhibition of cholinergic transmission in rat isolated trachea by potassium channel openers.
Fabiani ME; Vlahos R; Story DF
Pharmacol Res; 1996; 33(4-5):261-72. PubMed ID: 8938019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
